马来西亚别嘌醇致严重皮肤不良反应发生率
该研究基于马来西亚国家药品监管机构2015至2019年上报数据,回顾性分析别嘌醇致严重皮肤不良反应(SCAR)的发生率。结果显示5年平均发生率为每1000名新用药者2.5例,呈下降趋势,史蒂文斯-约翰逊综合征最常见。
要点
- 别嘌醇致SCAR平均发生率2.5例/1000新用药者,2015年3.2降至2019年2.25。
- 史蒂文斯-约翰逊综合征占别嘌醇致SCAR的46.8%(143例)。
- 马来西亚三大族群中,华裔别嘌醇致SCAR百分比最高(3.18×10-4%)。
核心结论
- 2015至2019年马来西亚别嘌醇致SCAR估算发生率为每1000名新用药者2.5例,与台湾和泰国等亚洲国家报告的发生率一致。
研究设计与样本
- 回顾性分析,与马来西亚国家药品监管机构(NPRA)合作,提取2015至2019年所有别嘌醇致不良反应报告,识别SCAR病例并计算5年发生率。
主要发现
- 别嘌醇致SCAR平均发生率为每1000名新用药者2.5例,2015年为3.2例/1000新用药者,2019年降至2.25例/1000新用药者,尽管上报的不良反应病例数逐年增加。
- 史蒂文斯-约翰逊综合征是最常见的别嘌醇致SCAR类型,报告143例,占SCAR总报告数的46.8%。
- 马来西亚三大族群中,华裔的别嘌醇致SCAR百分比最高(3.18×10-4%),高于土著和印度裔。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Allopurinol is known to cause severe cutaneous adverse drug reactions (SCAR) in Malaysia. However, the incidence of allopurinol-induced SCAR is unknown. Therefore, we aimed to determine the incidence of allopurinol-induced SCAR in Malaysia over 5 years from 2015 to 2019. METHODS: This retrospective analysis was done in collaboration with the National Pharmaceutical Regulatory Agency (NPRA). All allopurinol-induced adverse drug reaction cases reported to NPRA from 2015 to 2019 were extracted. Allopurinol-induced SCAR cases were identified and the incidence over the 5 years was calculated. RESULTS: Incidence of allopurinol-induced SCAR averaged at 2.5 cases per 1000 new users over the 5-year period, with a reducing trend from 3.2 per 1000 new users in 2015 to 2.25 per 1000 in 2019; despite the increasing number of adverse drug reaction cases being reported over the years. Stevens-Johnson syndrome was the commonest form of allopurinol-induced SCAR reported, at 143 cases (46.8% of total SCAR reported). Among Malaysia's 3 main ethnicities, the Chinese had the highest percentages of allopurinol-induced SCAR when compared to the Bumiputera and Indians (3.18 × 10-4 %). CONCLUSION: The estimated incidence of allopurinol-induced SCAR in Malaysia from 2015 to 2019 was 2.5 cases per 1000 new users. This figure is consistent with the incidence reported in other Asian countries, namely Taiwan and Thailand.
引用
- Ng WL, Lim KS, Hariraj V, et al. Incidence of allopurinol-induced severe cutaneous adverse drug reaction in Malaysia. Br J Clin Pharmacol. 2022. PMID: 35318720. doi:10.1111/bcp.15327
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。